Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
Location: Ireland
Total raised: $3.51M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.02.2026 | Seed | $3.51M | Enterprise... |
Mentions in press and media 4
| Date | Title | Description |
| 07.04.2026 | ArrayPatch Ltd Announces Acquisition of Microneedle Patch Drug Delivery Technology for Delivery of Peptides | Waleed Faisal, CEO and Co-Founder New IP acquisition positions ArrayPatch to enter high-growth peptide therapeutics markets, including diabetes and metabolic disorders. CORK, CO. CORK, IRELAND, April 7, 2026 /EINPresswire.com/ -- ArrayPatch... |
| 10.02.2026 | ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus | CORK, Ireland, Feb. 10, 2026 /PRNewswire/ -- ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding round, to advance its lead program ITZ-DerMa... |
| 18.11.2024 | Three Irish start-ups selected for semi-finals of EIT Health Catapult | Three innovative Irish healthcare start-ups have advanced to the next round of the prestigious EIT Health Catapult 2024-25 pitching competition. EIT Health Ireland-UK, a co-location centre of EIT Health and part of the EU's European Institu... |
| - | ArrayPatch | “Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.” |